首页> 外文期刊>Radiochimica Acta: International Journal for Chemical Aspects of Nuclear Science and Technology >Synthesis, characterization, and in vitro evaluation of a radio-metal organic framework composed of in vivo generator Dy-166/Ho-166 and DOTMP as a novel agent for bone marrow ablation
【24h】

Synthesis, characterization, and in vitro evaluation of a radio-metal organic framework composed of in vivo generator Dy-166/Ho-166 and DOTMP as a novel agent for bone marrow ablation

机译:由体内生成物Dy-166 / Ho-166和DOTMP组成的放射性金属有机骨架的合成,表征和体外评估

获取原文
获取原文并翻译 | 示例
           

摘要

In this study, the MOF concept contributed to the preparation of a novel, bone-ablating agent composed of Cu(II) using the in vivo generator Dy-166/Ho-166 and 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetramethylene phosphonic acid (DOTMP). The product was characterized (IR, elemental analysis: CHN, ICM-MS, PIXE, DLS, XRD) and quality-controlled (radio-thin layer chromatography (RTLC)). The stability and in vitro hydroxyapatite binding was checked up to one week at 37 degrees C in human serum. Radio-MOF crystals and colloidal radio-MOF particles were obtained by varying the synthesizing conditions (including pH and temperature), and they had similar IR patterns and similar elemental analysis results. The estimated chemical formula was [1Lu-1Cu-1Cl-1DOTMP] for both. The final product was synthesized at pH=8 while stirring at room temperature using Dy-166/Ho-166-nitrate, CuCl2, and DOTMP (yield > 99%, RTLC). Dynamic light scattering (DLS) measurements showed particles in the size range of 60 to 100 nm for the resultant radio-MOF-particles (RMP). In vitro binding experiments showed acceptable bone-seeking affinity of the prepared formula even after one week of storage in human serum at 37 degrees C. Importantly, this is the first study of the use of the MOF concept to provide a highly-stable organometallic compound containing Dy-166/Ho-166 in vivo generator for bone marrow ablation.
机译:在这项研究中,MOF的概念有助于使用体内生成剂Dy-166 / Ho-166和1,4,7,10-四氮杂环十二烷-1,由Cu(II)组成的新型骨消融剂的制备, 4,7,10-四亚甲基膦酸(DOTMP)。对产品进行了表征(红外,元素分析:CHN,ICM-MS,PIXE,DLS,XRD)和质量控制(放射性薄层色谱法(RTLC))。在人血清中在37摄氏度下检查稳定性和体外羟基磷灰石结合长达1周。通过改变合成条件(包括pH和温度)获得了放射性MOF晶体和胶态放射性MOF颗粒,它们具有相似的红外图谱和相似的元素分析结果。两者的估计化学式均为[1Lu-1Cu-1Cl-1DOTMP]。使用Dy-166 / Ho-166-硝酸盐,CuCl2和DOTMP在室温下搅拌的同时,在pH = 8的条件下合成最终产物(收率> 99%,RTLC)。动态光散射(DLS)测量显示,所得的放射性MOF粒子(RMP)的粒径范围为60至100 nm。体外结合实验显示,即使在37摄氏度的人血清中保存一周后,制得的配方仍具有可接受的寻骨亲和力。重要的是,这是首次使用MOF概念提供高度稳定的有机金属化合物包含Dy-166 / Ho-166体内用于骨髓消融的发生器。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号